Although some studies have suggested elevated ProGRP levels in advanced or poorly differentiated MTC, the evidence remains limited, and no standardized diagnostic thresholds or prognostic algorithms have been established. The gene discussed is GRP; the disease is medullary thyroid gland carcinoma.